NEK2 and Ferroptosis in Gastric Cancer
Author Information
Author(s): Wu Jianyong, Luo Desheng, Tou Laizhen, Xu Hongtao, Jiang Chuan, Wu Dan, Que Haifeng, Zheng Jingjing
Primary Institution: Lishui Municipal Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China
Hypothesis
Inhibition of NEK2 enhances the sensitivity of gastric cancer cells to ferroptosis.
Conclusion
Inhibiting NEK2 increases the sensitivity of gastric cancer cells to ferroptosis by promoting HMOX1 expression through the Keap1/Nrf2 signaling pathway.
Supporting Evidence
- Inhibition of NEK2 enhances the sensitivity of gastric cancer cells to ferroptosis.
- NEK2 regulates HMOX1 expression through the Keap1/Nrf2 signaling pathway.
- Blocking NEK2 leads to increased levels of Fe2+, ROS, and lipid peroxidation in gastric cancer cells.
- NEK2 knockdown increases the expression of ferroptosis-related genes.
- Inhibition of HMOX1 on the basis of NEK2 knockdown restores cell viability.
Takeaway
This study shows that blocking a protein called NEK2 helps stomach cancer cells die more easily by a process called ferroptosis, which is linked to another protein called HMOX1.
Methodology
The study used cell viability assays, RNA-seq, and various biochemical assays to analyze the effects of NEK2 inhibition on gastric cancer cells.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website